Cytek Biosciences Stock Forward View - Day Typical Price
| CTKB Stock | USD 5.00 0.01 0.20% |
Cytek Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Cytek Biosciences stock prices and determine the direction of Cytek Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cytek Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Cytek Biosciences' share price is at 50 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Cytek Biosciences, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.735 | EPS Estimate Next Quarter 0.035 | EPS Estimate Current Year 0.015 | EPS Estimate Next Year (0.01) | Wall Street Target Price 6 |
Using Cytek Biosciences hype-based prediction, you can estimate the value of Cytek Biosciences from the perspective of Cytek Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytek Biosciences using Cytek Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytek using crowd psychology based on the activity and movement of Cytek Biosciences' stock price.
Cytek Biosciences Implied Volatility | 2.12 |
Cytek Biosciences' implied volatility exposes the market's sentiment of Cytek Biosciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytek Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytek Biosciences stock will not fluctuate a lot when Cytek Biosciences' options are near their expiration.
Cytek Biosciences after-hype prediction price | USD 5.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cytek Biosciences to cross-verify your projections. Open Interest Against 2026-04-17 Cytek Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cytek Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cytek Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cytek Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cytek Biosciences' open interest, investors have to compare it to Cytek Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cytek Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cytek. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Cytek Biosciences Additional Predictive Modules
Most predictive techniques to examine Cytek price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytek using various technical indicators. When you analyze Cytek charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Day Typical Price | Day Typical Price | Trend |
| 5.01 | 4.98 |
| Check Cytek Biosciences Volatility | Backtest Cytek Biosciences | Information Ratio |
Cytek Biosciences Trading Date Momentum
| On January 30 2026 Cytek Biosciences was traded for 5.00 at the closing time. The top price for the day was 5.09 and the lowest listed price was 4.86 . The trading volume for the day was 848.3 K. The trading history from January 30, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.40% . |
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Cytek Biosciences to competition |
Other Forecasting Options for Cytek Biosciences
For every potential investor in Cytek, whether a beginner or expert, Cytek Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cytek Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cytek. Basic forecasting techniques help filter out the noise by identifying Cytek Biosciences' price trends.Cytek Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytek Biosciences stock to make a market-neutral strategy. Peer analysis of Cytek Biosciences could also be used in its relative valuation, which is a method of valuing Cytek Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cytek Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Cytek Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytek Biosciences shares will generate the highest return on investment. By undertsting and applying Cytek Biosciences stock market strength indicators, traders can identify Cytek Biosciences entry and exit signals to maximize returns.
Cytek Biosciences Risk Indicators
The analysis of Cytek Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cytek Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytek stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.85 | |||
| Semi Deviation | 2.76 | |||
| Standard Deviation | 4.38 | |||
| Variance | 19.17 | |||
| Downside Variance | 8.77 | |||
| Semi Variance | 7.62 | |||
| Expected Short fall | (3.43) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cytek Biosciences
The number of cover stories for Cytek Biosciences depends on current market conditions and Cytek Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytek Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytek Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Cytek Biosciences Short Properties
Cytek Biosciences' future price predictability will typically decrease when Cytek Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytek Biosciences often depends not only on the future outlook of the potential Cytek Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytek Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 130.6 M | |
| Cash And Short Term Investments | 277.9 M |
Check out Historical Fundamental Analysis of Cytek Biosciences to cross-verify your projections. For information on how to trade Cytek Stock refer to our How to Trade Cytek Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytek Biosciences. Projected growth potential of Cytek fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytek Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.735 | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth 0.015 | Return On Assets |
Investors evaluate Cytek Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cytek Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Cytek Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Cytek Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytek Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cytek Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.